As a first step in understanding the role of decidual PRL-related protein
interface. It has long been speculated that the decidua plays a critical role in the establishment of pregnancy, but knowledge concerning the exact mechanism(s) by which it does so is limited. Postulated functions of decidual cells include 1) providing a nutritive role in maintenance of the embryo before development of the fetal circulatory system, 2) limiting invasion of trophoblast cells into the uterus, 3) preventing immunological rejection of the fetal allograft, and 4) producing hormones that act in paracrine or endocrine modes to influence the functions of embryonic, extraembryonic, or maternal tissues (l-3). The latter function is probably fundamental to each of the responsibilities of decidual cells. The present study focuses on a protein produced by decidual cells, termed decidual PRL-related protein (dPRP). dPRP was first identified in rat decidual tissue based on its homology with members of the placental PRL family (4) 137: 5558-5566, 1996) dPRP protein and complementary DNA (cDNA) have been isolated and characterized (4). dPRP is a 29-kDa glycoprotein with approximately 70% amino acid sequence homology to a member of the placental PRL family, PRL-like protein C (PLP-C) (4, 5) . Another member of the PRL family, PRL-like protein B, is antigenically related to dPRP and has been shown to be expressed in rat decidual cells (6). In addition, evidence exists for the presence of a rat decidual protein related to PRL possessing actions on the ovary and uterus (7, 8) . Whether dPRP or PLP-B is responsible for these ovarian and uterine PRL-like effects remains to be determined.
To begin to determine the biological actions of dPRP during the establishment of pregnancy, we used the dPRP cDNA to express the dPRP protein. In this report, we describe the isolation and characterization of recombinant rat dPRP, the generation of antibodies to dPRP, and the utilization of these tools to investigate the biology of dPRP. Results Heterologous dPRP expression and purification CHO cells transfected with the dPRP expression vector produced a 29-kDa protein with immunochemical, electrophoretic, and biochemical characteristics similar to those of native dPRP (Figs. l-3) . dPRP production was initially examined with antipeptide antibodies directed to amino acids 140-159 of PLP-B. These antibodies are known to recognize dPRP (4) and specifically cross-reacted with a 29-kDa protein in CHO-dPRP cell-conditioned medium (Fig. 1 ). Antibodies to recombinant PLP-A did not recognize any proteins in the CHO-dPRP cell-conditioned medium (Fig. 1) . The 29-kDa recombinant dPRP was purified to homogeneity from conditioned medium of CHO cells stably transfected with the pRdPRP expression vector using gel filtration and reverse phase HPLC (Fig. 2) . N-Terminal sequence analysis of the 29-kDa protein isolated from conditioned medium (Val'-Pro*-Ala3-XxX4-His5) confirmed its identity with the N-terminal sequence of native dPRP and the amino acid sequence predicted from the dPRP cDNA (4). Recombinant dPRP was used to generate polyclonal antibodies. Immunoblot analysis of the reactivity of the antisera indicated that antibodies directed to recombinant dPRP specifically recognized a protein with a mol wt of 29 kDa; this was evident in immunoblots made from decidual cytosol preparations and conditioned medium from decidual and CHO-dPRP cells (Fig. 3) . dPRP-heparin interactions dPRP was not detectable in serum from pseudopregnant decidualized rats, as measured by Western blot analysis (data not shown). In contrast, other members of the PRL family are abundantly present in maternal serum (34). Thus, we hypothesized that dPRP may have a more restricted distribution and possibly associate with the decidual ECM. Heparan sulfate proteoglycan is known to bind an array of cytokines and growth factors and was evaluated as a possible reservoir for dPRP (35). Heparin-Sepharose affinity chromatography has been used to characterize and purify a number of heparin-binding molecules, such as basic fibroblast growth factor (23), lipoprotein lipase (21), and heparin-binding epidermal growth factor (36). In the present experiments, dPRP was shown to bind strongly to heparin, requiring treatment with SDS for dissociation. Both native and recombinant dPRP bound to heparin in uitvo (Fig. 4) The putative heparin-binding domain was synthesized and tested for its ability to bind heparin. In a variety of experiments, we failed to show any significant affinity of the putative dPRP heparin-binding domain for heparin. To further characterize dPRP's ability to bind to heparin in viuo, CHO-dPRP cells were incubated with the glycosaminoglycan-degrading enzyme heparinase. As shown in Fig. 5 , heparinase-treated cultures released dPRP from the cellular monolayer. In contrast, there was little release of dPRP from vehicle-treated cultures. Collectively, these results suggest that dPRP may bind to a heparan sulfate proteoglycan. To further establish an in viva relationship between dPRP and decidual ECM, we extracted ECM from decidual tissue and tested for the presence of laminin and dPRP. Western blot analysis with antibodies to rat laminin revealed the presence of laminin in the decidual ECM preparation (data not shown). Our results also show the presence of dPRP in the ECM of decidual tissue (Fig. 5) .
Materials and Methods

Reagents
Characterization of PRL-like activities dPRP did not displace ovine PRL from ovarian or hepatic PRL receptors (Fig. 6 ) and showed negligible stimulating activity in the rat Nb, lymphoma cell proliferation assay (Table 1) 
Effects of dPRP on angiogenesis
Members of the PRL family have been shown to have effects on angiogenesis (37, 38) . This information in addition to the localization of dPRP to an area of the pregnant uterus with limited vacularization (39) led us to hypothesize that dPRP may be involved in the control of uterine blood vessel development. To examine the effects of dPRP on endothelial cells in vitro, we tested its ability to affect endothelial cell proliferation. Our experiments showed that dPRP had limited effects on endothelial cell proliferation (data not shown). A number of factors can stimulate angiogenesis in vivo without stimulatory effects on endothelial cells in vitro (40). To determine whether dPRP modulates angiogenesis in vivo, we tested its ability to affect tumor development in athymic (~10~~) are indicated at the left of the panel.
mice, similar to the procedure described by Ueki et al. (33) . Control CHO cells or CHO cells expressing dPRP or PLP-A generated solid tumors after SC transplantation in athymic mice. Histological examination of tumor tissue revealed no significant differences in the architecture or morphology of dPRP-producing tumors compared to that of control tumors (Fig. 7) . Lectin histochemical detection of endothelial cells detailed prominent neovascularization in both types of tumors (Fig. 7) . Immunoreactive dPRP was identified in the (Fig. 8) . Although dPRP expression did not affect tumor structure, a striking effect was noted in the incidence of the tumors (Table  2 ). There was a significantly greater percentage of mice injected with CHO cells expressing dPRP-generated tumors than of mice injected with control CHO cells or CHO cells expressing PLP-A ( Table 2) . The difference in tumor incidence was not correlated with in vitro growth rates of the cell populations.
Control In the present report, we expressed dPRP in CHO cells, clonal antibodies to recombinant dPRP, and used these reagents to dissect possible roles of dPRP in the uterus during pregnancy. Our strategy involved subcloning a dPRP cDNA into the pMSXND expression vector and using CHO cells as a host for the production of recombinant dPRP protein. This approach has been used for the generation of biologically active proteins representing other members of the PRL family, including proliferin (16), PL-I (41, 42), PL-II (43), and PLP-A (17). Polyclonal antibodies were generated to recombinant dPRP and greatly facilitated the characterization of native dPRP protein. Our findings indicate that recombinant dPRP is immunochemically and biochemically similar to native dPRP and possesses biologically relevant activities.
Tissue distribution of a hormone or cytokine has direct bearing on its accessibility to target cells. Some extracellular signals circulate free or bound to transport proteins, whereas others act locally, often tethered to the surface of cells or the was not supported by the experimental evidence, results from the in vivo analyses implicated dPRP in alternative physiological roles within the uterus. We used a tumor development model to evaluate the role of dPRP on angiogenesis.
In this model, the putative modulator is stably overexpressed in CHO cells and then transplanted into athymic mice (33). Tumor growth is directly related to the vascularization of the transplant. We did not observe any significant differences in the morphology, vascularity, or growth of control vs. dPRP-expressing tumors. Heterologous expression of dPRP in CHO cells was, however, associated with an increase in the ability of CHO cells to form tumors after transplantation into athymic mice. Thus, dPRP expression was correlated with an altered relationship between the tumor cells and their host, thereby increasing the success rate for establishing a tumor. In the future, it will be necessary to directly examine the effects of dPRP on tumor cell-host relationships.
Parallels between host regulatory events in tumor transplantation and establishment of the genetically foreign embryo within the uterus are evident (49). Natural killer (NK) cells and macrophages are potential effector cells in tumor resistance (50, 51) and have also been implicated in the maternal immune response to pregnancy (52, 53 
